Medicine and Dentistry
Neoplasm
100%
Nodular Melanoma
93%
Surgery
73%
Parathyroidectomy
64%
Cytoreductive Surgery
63%
Peritoneum Metastasis
52%
Hyperthermic Intraperitoneal Chemotherapy
52%
Diagnosis
51%
Papillary Thyroid Cancer
50%
Disease
49%
Recurrent Disease
42%
Adrenalectomy
40%
Secondary Hyperparathyroidism
38%
Primary Hyperparathyroidism
35%
End Stage Renal Disease
35%
Hyperparathyroidism
33%
Sentinel Node
33%
Retroperitoneal Lymph Node Dissection
32%
Systematic Review
32%
Bevacizumab
31%
Parathyroid Hormone
30%
Overall Survival
30%
Positron Emission Tomography-Computed Tomography
28%
Quality of Life
27%
Primary Hyperaldosteronism
26%
Tertiary Hyperparathyroidism
26%
Cancer Surgery
25%
Systemic Therapy
24%
Radioactive Tracer
24%
Parathyroid Adenoma
23%
Parathyroid
23%
Thyroid Cancer
22%
Sentinel Lymph Node Biopsy
22%
Carbon 11
21%
Meningioma
21%
Health Care Cost
21%
Kidney Transplantation
21%
Thyroidectomy
20%
Isotopes of Calcium
20%
Cohort Analysis
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
COVID-19
20%
Calcimimetic
19%
Malignant Neoplasm
19%
Retrospective Cohort Study
19%
Surgeon
18%
Sentinel Lymph Node
17%
Meta-Analysis
17%
Laparoscopy
17%
Biological Marker
17%
Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
44%
Colorectal Peritoneal Metastases
35%
S100B
26%
Melanoma Patients
25%
Parathyroidectomy
24%
Kidney Transplantation
20%
Computed Tomography
19%
Surgical Treatment
17%
Primary Hyperparathyroidism (pHPT)
17%
Hyperparathyroidism
16%
Diagnostic Laparoscopy
16%
Primary Aldosteronism
16%
Completion Lymph Node Dissection
14%
Cytoreductive Surgery
14%
Peritoneal Cancer Index
14%
Node-positive
13%
Retrospective Cohort Study
12%
Overall Survival
12%
Adrenalectomy
12%
Abdominal Cancer Surgery
11%
Parathyroid Adenoma
11%
Stage III Melanoma
11%
End-stage Renal Disease
11%
Melanoma
11%
Graft Outcome
10%
Physical Activity
10%
Health Care Costs
10%
Death-censored Graft Survival
10%
Patient Outcomes
10%
Octreotate
10%
Anorectal Melanoma
10%
Narrative Review
10%
Non-sentinel Node
10%
Selection Tool
10%
Cinacalcet
10%
Meta-analysis
10%
Systematic Meta-analysis
10%
Local Excision
9%
Aggressive Resection
9%
Non-associated
9%
Survival Outcomes
9%
Surgical Outcomes
9%
Prognostic Factors
8%
Sentinel Lymph Node
8%
International Cohort
8%
Fluorescence-guided Surgery
8%
Tertiary Hyperparathyroidism
8%
Diagnostic Work-up
8%
Patient Selection
7%
Academic Center
7%
